This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $2,873,042.91 contract is for the Medicinal Chemistry Support Program for Therapeutic Development, under which Curia will provide a range of chemistry, manufacturing, and controls development...
This is a $3,453,835.19 delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, a for-profit manufacturer. The contract is for the Medicinal Chemistry Support Program for Therapeutic Development, which provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry;...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract...
This federal contract award to Curia Global Inc., doing business as Amri, is a delivery order under the Drug Manufacturing and Formulation Program (DMFP) indefinite-delivery/indefinite-quantity (IDIQ) contract with the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,058,963 cost-plus-fixed-fee contract is for chemistry, manufacturing, and controls development services, exploratory chemistry,...
This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a...
This federal contract award, valued at $2,592,564.37, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc. (doing business as Amri), a leading global contract development and manufacturing organization (CDMO). The award is for a Delivery Order under the Biomedical Prototype Network - Medicinal Chemistry Support Program for Therapeutic Development (BPN-MCSP-HIT) to support chemistry-related services, including hit-to-lead chemistry, for the Martin...
This contract award is for Task Order C02 under the Nonclinical Services for Development of Interventional Agents master IDIQ contract, which was awarded to Curia Global Inc. (doing business as Amri), a global contract development and manufacturing organization (CDMO). The $542,766.00 cost-plus-fixed-fee task order was awarded on March 22, 2019 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). This task order...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $815,714.07. The contract is for medicinal chemistry services to support the "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP" project, which is part of NINDS's Medicinal Chemistry Support Program for therapeutic development. Curia, a...
This is a delivery order under indefinite-delivery/indefinite-quantity (IDIQ) contract HHSN271201800001I awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The $1,796,372.11 contract is for "HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2" of the Medicinal Chemistry Support Program for Therapeutic Development. Curia, a leading global contract development and...
This is a $13,300 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS) to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The contract is for X-ray crystallography studies of ALDH1A2 in complex with a small molecule inhibitor, as part of NCATS' drug discovery and development efforts. No set-aside designation was used. Curia has extensive experience supporting various...
This $142,500 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a global contract development and manufacturing organization (CDMO). The contract is for sequencing services to identify molecules that bind the KIAA0203 protein, in support of the NIH's preclinical drug discovery efforts. No set-aside designation was used. Curia has provided chemistry, manufacturing, and controls development services, exploratory chemistry, hit-to-lead chemistry, and other pharmaceutical research and development support to various NIH entities through prime and subcontract awards, including the Medicinal Chemistry Support Program and the Drug Manufacturing and Formulation Program.